253 related articles for article (PubMed ID: 29783685)
1. Novel Imidazole Aldoximes with Broad-Spectrum Antimicrobial Potency against Multidrug Resistant Gram-Negative Bacteria.
Skočibušić M; Odžak R; Ramić A; Smolić T; Hrenar T; Primožič I
Molecules; 2018 May; 23(5):. PubMed ID: 29783685
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and antimicrobial profile of N-substituted imidazolium oximes and their monoquaternary salts against multidrug resistant bacteria.
Odžak R; Skočibušić M; Maravić A
Bioorg Med Chem; 2013 Dec; 21(23):7499-506. PubMed ID: 24126094
[TBL] [Abstract][Full Text] [Related]
3. Antimicrobial activity of ceftazidime-avibactam and comparator agents when tested against bacterial isolates causing infection in cancer patients (2013-2014).
Sader HS; Castanheira M; Jones RN; Flamm RK
Diagn Microbiol Infect Dis; 2017 Mar; 87(3):261-265. PubMed ID: 28069328
[TBL] [Abstract][Full Text] [Related]
4. Antimicrobial Activity of Ceftazidime-Avibactam against Gram-Negative Bacteria Isolated from Patients Hospitalized with Pneumonia in U.S. Medical Centers, 2011 to 2015.
Sader HS; Castanheira M; Flamm RK
Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28069649
[TBL] [Abstract][Full Text] [Related]
5. Activity of ceftazidime-avibactam against multidrug-resistance Enterobacteriaceae expressing combined mechanisms of resistance.
López-Hernández I; Alonso N; Fernández-Martínez M; Zamorano L; Rivera A; Oliver A; Conejo MC; Martínez-Martínez L; Navarro F; Pascual A
Enferm Infecc Microbiol Clin; 2017 Oct; 35(8):499-504. PubMed ID: 27887765
[TBL] [Abstract][Full Text] [Related]
6. Activity of Ceftazidime-Avibactam against Extended-Spectrum- and AmpC β-Lactamase-Producing Enterobacteriaceae Collected in the INFORM Global Surveillance Study from 2012 to 2014.
Karlowsky JA; Biedenbach DJ; Kazmierczak KM; Stone GG; Sahm DF
Antimicrob Agents Chemother; 2016 May; 60(5):2849-57. PubMed ID: 26926635
[TBL] [Abstract][Full Text] [Related]
7. Relationship between the distribution of cefepime minimum inhibitory concentrations and detection of extended-spectrum β-lactamase production among clinically important Enterobacteriaceae isolates obtained from patients in intensive care units in Taiwan: results from the Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART) in 2007.
Jean SS; Lee WS; Bai KJ; Lam C; Hsu CW; Yu KW; Liao CH; Chang FY; Ko WC; Wu JJ; Chen YH; Chen YS; Liu JW; Lu MC; Liu CY; Chen RJ; Hsueh PR
J Microbiol Immunol Infect; 2015 Feb; 48(1):85-91. PubMed ID: 23973410
[TBL] [Abstract][Full Text] [Related]
8. Extended-spectrum beta-lactamase-mediated resistance among bacterial isolates recovered from ocular infections.
Jayahar Bharathi M; Ramakrishnan R; Ramesh S; Murugan N
Ophthalmic Res; 2012; 47(1):52-6. PubMed ID: 21720185
[TBL] [Abstract][Full Text] [Related]
9. Ceftazidime-avibactam activity tested against Enterobacteriaceae isolates from U.S. hospitals (2011 to 2013) and characterization of β-lactamase-producing strains.
Castanheira M; Mills JC; Costello SE; Jones RN; Sader HS
Antimicrob Agents Chemother; 2015; 59(6):3509-17. PubMed ID: 25845862
[TBL] [Abstract][Full Text] [Related]
10. New and Potent Quinuclidine-Based Antimicrobial Agents.
Radman Kastelic A; Odžak R; Pezdirc I; Sović K; Hrenar T; Čipak Gašparović A; Skočibušić M; Primožič I
Molecules; 2019 Jul; 24(14):. PubMed ID: 31340589
[TBL] [Abstract][Full Text] [Related]
11. Extended-spectrum beta-lactamase producing strains of Enterobacter cloacae transferring resistance to cefotaxime and ceftazidime.
Blahová J; Králiková K; Krcméry V; Schäfer V
J Chemother; 1999 Apr; 11(2):97-102. PubMed ID: 10326739
[TBL] [Abstract][Full Text] [Related]
12. Assessment of the In Vitro Activity of Ceftazidime-Avibactam against Multidrug-Resistant Klebsiella spp. Collected in the INFORM Global Surveillance Study, 2012 to 2014.
Hackel M; Kazmierczak KM; Hoban DJ; Biedenbach DJ; Bouchillon SK; de Jonge BL; Stone GG
Antimicrob Agents Chemother; 2016 Aug; 60(8):4677-83. PubMed ID: 27216054
[TBL] [Abstract][Full Text] [Related]
13. Antimicrobial susceptibility and beta-lactamase production of selected gram-negative bacilli from two Croatian hospitals: MYSTIC study results.
Bedenic B; Goic-Barisic I; Budimir A; Tonkic M; Mihajkevic LJ; Novak A; Sviben M; Plecko V; Punda-Polic V; Kalenic S
J Chemother; 2010 Jun; 22(3):147-52. PubMed ID: 20566417
[TBL] [Abstract][Full Text] [Related]
14. In vitro activity of avibactam (NXL104) in combination with β-lactams against Gram-negative bacteria, including OXA-48 β-lactamase-producing Klebsiella pneumoniae.
Aktaş Z; Kayacan C; Oncul O
Int J Antimicrob Agents; 2012 Jan; 39(1):86-9. PubMed ID: 22041508
[TBL] [Abstract][Full Text] [Related]
15. Ceftazidime/avibactam tested against Gram-negative bacteria from intensive care unit (ICU) and non-ICU patients, including those with ventilator-associated pneumonia.
Sader HS; Castanheira M; Flamm RK; Mendes RE; Farrell DJ; Jones RN
Int J Antimicrob Agents; 2015 Jul; 46(1):53-9. PubMed ID: 25956844
[TBL] [Abstract][Full Text] [Related]
16. Antimicrobial Activity of High-Proportion Cefepime-Tazobactam (WCK 4282) against a Large Number of Gram-Negative Isolates Collected Worldwide in 2014.
Sader HS; Castanheira M; Mendes RE; Flamm RK; Jones RN
Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28137811
[TBL] [Abstract][Full Text] [Related]
17. Bactericidal activity of ertapenem against major intra-abdominal pathogens.
Borbone S; Cascone C; Santagati M; Mezzatesta ML; Stefani S
Int J Antimicrob Agents; 2006 Nov; 28(5):396-401. PubMed ID: 17045463
[TBL] [Abstract][Full Text] [Related]
18. Beta-lactamase-producing Enterobacteriaceae in hospital effluents.
Korzeniewska E; Harnisz M
J Environ Manage; 2013 Jul; 123():1-7. PubMed ID: 23563146
[TBL] [Abstract][Full Text] [Related]
19. Concentration-dependency of beta-lactam-induced filament formation in Gram-negative bacteria.
Buijs J; Dofferhoff AS; Mouton JW; Wagenvoort JH; van der Meer JW
Clin Microbiol Infect; 2008 Apr; 14(4):344-9. PubMed ID: 18261128
[TBL] [Abstract][Full Text] [Related]
20. In vitro susceptibility of characterized β-lactamase-producing Gram-negative bacteria isolated in Japan to ceftazidime-, ceftaroline-, and aztreonam-avibactam combinations.
Yoshizumi A; Ishii Y; Aoki K; Testa R; Nichols WW; Tateda K
J Infect Chemother; 2015 Feb; 21(2):148-51. PubMed ID: 25444674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]